Yeah, docs getting money from pharma companies is so much

New Post Public Reply Private Reply Replies (1) Message Board
Respert24 SporadicE #142787
692
Yeah, docs getting money from pharma companies is so much more limited these last 10+ years than it was before. There is a database to track what each doctor receives from pharma so you can look it up as a patient. There are all sorts of rules in place for a dinner program, which is/was a very common practice at the territory level and one of the main ways doctors got paid. In 2004 you could take a doctor out to dinner for no reason. It wasn't but a year or two later before it had to be a speaking engagement with attendees. Had to be run through the organization and the limits and rules were tight. It honestly started to feel like a waste of time.

That being said, the "gurus" in each region were definitely being asked to speak about drugs and taking a payday to do so. But they were also held to an approved speaker deck of presentation materials and outside of offering their unique thoughts during Q&A it was always frustrating that these "thought leaders" were taking a nice paycheck home for delivering the same information the reps were delivering in the field. They just did it over either steak, salmon, or chicken with house wine or beer included.

There's a LOT of nuance that goes into what a doctor prescribes, including if they're being paid. Just because they're paid doesn't mean it's not still the best drug. It doesn't mean that they could even prescribe another, as insurance companies are like fucking mob bosses about what they allow doctors to do. Or put another way, what they will cover.

I remember a primary care doctor telling me he was no longer allowed to perform the two common (and complimentary) tests for heart health in his office on the same day anymore. They'd literally still cover/pay for both, but they wanted to make the patient come back for a second visit. No way around it for the doctors.

Bottom line, while pharma takes the brunt of the furor it's insurance companies that deserve a significant chunk of that frustration.

But back to the prescribers. They will often take the path of least resistance. If it's covered on their major plan they start there for every patient because they're less likely to find out the patient's insurance won't cover it or that the patient shows up to the pharmacy and finds out the cost of their script is $450. They blame the doc when it's really more of an insurance issue.

Insurance companies get rebates from the pharma companies by moving certain quantities of their drugs, so it's in their best interest to keep prices down by forcing doctors to prescribe what makes them the most money.

I've probably told it here before, but the head of trauma urology at a major hospital system once told a crowd of doctors that his hospital had multiple days of meetings to try to figure out if they should continue the older TUNA procedure that has more side effects but gets you more money out of the insurance carrier, or perform the newer and safer TURP that paid a quarter of the reimbursement. They finally settled on doing the TURP since it was best for the patient, but it wasn't an easy decision when for profit assholes are staring at what could be a cash cow instead of settling for an ATM with a withdrawal limit.

It's a bell curve. Most are good, solid doctors. A small amount are great and a small amount are terrible. But they also are stuck in a system that is dysfunctional at just about every level. I found that most tried quite hard to do what was right even though it was a more difficult path to take.

And to the folks talking about having a billionaire try an end around toward approval, it's both never going to happen and a terrible idea.

You've all probably heard the phrase "you never call another person's baby a Craig". Despite our thoughts on the organization, they are in full control and would be happy to delay a company who Amarex's their way through the process with concerns over spelling errors or missing punctuation.

It would be company seppuku to signal to the fda that we don't plan on playing their games. It's a bad system but it's too big and too entrenched as an entity to do anything about it while we're all still kicking.

Besides, we're already not owned by big pharma and already working on doing trials. Sure, it would be great if we knew where our money was coming from but we'll get there. Why try to skirt the system when we can latch onto it like a puppy and hump our way to approval the old fashioned way. By earning it.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rural AI Skills Gap Uncovered: Challenges and Solutions

Updated Category News Views 179

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Continue Reading
Shenzhen's Theme Song Unveils APEC 2026 Vision

Updated Category News Views 107

A Harmonious Prelude to APEC China 2026 Ever experienced an anthem that captures a city's pulse? That's what Shenzhen's latest creation aims for as it gears up for APEC China 2026. The Publicity Department of the CPC Shenzhen Municipal Committee, alongside Shenzhen Media Group, has crafted something more than just a tune. This is 'Meet You Where Wonders Bloom', a melody...

Continue Reading
Navigating the Maze of Required Minimum Distributions

Updated Category News Views 52

Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...

Continue Reading
Ensuring Flooring Stability: Acclimation's Key Role

Updated Category News Views 11

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Continue Reading
Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 261

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
iTLC Traffic Systems Expand Global Reach at APTA 2026

Updated Category News Views 195

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Continue Reading
Mastering Progressive Overload: Break Workout Plateaus

Updated Category News Views 36

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...

Continue Reading
NIDS Aims Global with CES 2027, Boosts Sensor Supply

Updated Category News Views 263

Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...

Continue Reading
SAMILBIO Gambles on 'Chaeyun' Launch With November Events

Updated Category News Views 52

Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...

Continue Reading
Bass Angler Matt Robertson Reels in Record $1.25M Prize

Updated Category News Views 195

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Continue Reading

Top 5 Most Recently Viewed Articles

Ensolum Welcomes Eric Matzner: A New Era in Geology Services

Updated Category News Views 194

Ensolum, LLC Welcomes Eric Matzner as Senior Managing Geologist Ensolum, LLC is delighted to welcome Eric Matzner, PG to our team as the new Senior Managing Geologist. With 30 years of diverse hydrogeology consulting experience, Eric is set to enhance our environmental services. His appointment comes as we expand our operations with a new office in Austin, bringing an...

Continue Reading
Understanding Stroke Prevention and Recognition for Everyone

Updated Category News Views 238

Understanding Stroke and Its Prevention Strokes can happen unexpectedly and affect anyone, regardless of age. They stand as one of the primary causes of death and long-term disability. However, with knowledge and action, the impact of strokes can be significantly controlled. Recognizing risk factors and managing health effectively can save lives. The Urgency of...

Continue Reading
Penumbra, Inc. Announces Retirement of Board Director Don Kassing

Updated Category News Views 275

Penumbra, Inc. Announces the Retirement of Don Kassing Penumbra, Inc. (NYSE: PEN), a renowned thrombectomy company, recently shared significant news regarding its Board of Directors. After an impressive 17 years of dedicated service, Don Kassing has announced his decision to retire from the board, effective this spring. His journey with Penumbra began back in 2008, and...

Continue Reading
Stifel Financial's Upcoming Earnings: What to Expect

Updated Category News Views 72

Insights on Stifel Financial's Earnings Forecast Stifel Financial (NYSE: SF) is set to announce its quarterly earnings soon, and there’s a palpable buzz in the investor community. This earnings report will offer valuable insights into the company's financial health and future prospects. Analysts predict that Stifel Financial will post an earnings per share (EPS) of...

Continue Reading
Dana Incorporates Innovation in Financial Results Announcement

Updated Category News Views 188

Dana Incorporated Shares Financial Insights for Q2 2025 Dana Incorporated (NYSE: DAN) is announcing its financial results for the second quarter of 2025. This announcement is set to take place on a Tuesday in early August, with the company's financial results expected to release at around 7 a.m. EDT. The senior management team will hold a conference call and webcast...

Continue Reading